COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1320: Articles 13191-13200  | Next

Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19
Kousathanas, A., Pairo-Castineira, E., Rawlik, K., Stuckey, A., Odhams, C. A., Walker, S., Russell, C. D., Malinauskas, T., Millar, J., Elliott, K. S., Griffiths, F., Oosthuyzen, W., Morrice, K., Keating, S., Wang, B., Rhodes, D., Klaric, L., Zechner, M., Parkinson, N., Bretherick, A. D., Siddiq, A., Goddard, P., Donovan, S., Maslove, D., Nichol, A., Semple, M. G., Zainy, T., Maleady-Crowe, F., Todd, L., Salehi, S., Knight, J., Elgar, G., Chan, G., Arumugam, P., Fowler, T. A., Rendon, A., Shankar-Hari, M., Summers, C., Elliott, P., Yang, J., Wu, Y., GenOMICC Investigators, , 23andMe Investiga
10.1101/2021.09.02.21262965 — Posted: 2021-09-02
Structural and Biochemical Rationale for Enhanced Spike Protein Fitness in Delta and Kappa SARS-CoV-2 Variants
Saville, J. W., Mannar, D., Zhu, X., Srivastava, S. S., Berezuk, A. M., Demers, J.-P., Zhou, S., Tuttle, K., Sekirov, I., Kim, A., Li, W., Dimiter, D. S., Subramaniam, S.
10.1101/2021.09.02.458774 — Posted: 2021-09-02
Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
Liu, Y., Liu, J., Zou, J., Ren, P., Weaver, S., Xie, X., Shi, P.-Y.
10.1101/2021.09.02.458740 — Posted: 2021-09-02
Ensemble forecast of COVID-19 in Karnataka for vulnerability assessment and policy interventions
Ganesan, S., Subramani, D., Anandh, T., Ghose, D., Babu, G. R.
10.1101/2021.08.31.21262943 — Posted: 2021-09-02
Deep immune profiling reveals early-stage and highly coordinated immune responses in mild COVID-19 patients
Capelle, C. M., Cire, S., Domingues, O., Ernens, I., Hedin, F., Fischer, A., Snoeck, C., Ammerlaan, W., Konstantinou, M., Grzyb, K., Skupin, A., Carty, C. L., Hilger, C., Gilson, G., Celebic, A., Del Sol, A., Kaplan, I. M., Betsou, F., Abdelrahman, T., Cosma, A., Vaillant, M. T., Fagherazzi, G., Ollert, M., Hefeng, F. Q.
10.1101/2021.08.31.21262713 — Posted: 2021-09-02
Nanobody-Functionalized Cellulose for Capturing and Containing SARS-CoV-2
Sun, X., Yang, S., Al-Dossary, A., Broitman, S., Ni, Y., Yang, M., Li, J.
10.1101/2021.09.01.458653 — Posted: 2021-09-02
High diversity in Delta variant across countries revealed via genome-wide analysis of SARS-CoV-2 beyond the Spike protein
Ghosh, P., Suratekar, R., Niesen, M. J. M., Anand, P., Donadio, G., Soundararajan, V., Venkatakrishnan, A.
10.1101/2021.09.01.458647 — Posted: 2021-09-02
Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19
Lin, X., Ke, X., Lin, X., Zhang, T., Xiong, H., Zhao, B., Liu, W., Chen, Q., Tang, C.
10.1101/2021.09.01.458475 — Posted: 2021-09-02
Co-expression analysis to identify key modules and hub genes associated with COVID19 in Platelets
Alarabi, A. B., Mohsen, A., Mizuguchi, K., Alshbool, F. Z., Khasawneh, F. T.
10.1101/2021.09.01.458644 — Posted: 2021-09-02
Modelling the potential role of super spreaders on COVID-19 transmission dynamics
Mushanyu, J., Chukwu, W., Nyabadza, F., Muchatibaya, G.
10.1101/2021.08.30.21262341 — Posted: 2021-09-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).